Synecor LLC

The first challenge to Johnson & Johnson ’s coronary angioplasty business came from Guidant Corp. ’s introduction of a stent with greater flexibility and an improved delivery balloon catheter. T

A percutaneous intravascular cardioverter-defibrillator (PICD) matched a traditional ICD in a small defibrillation threshold study, and the investigators believe it could eventually be a safer alterna

Device incubators have had their ups and downs. With two recent successful exits, has The Foundry proven that the model works? by David Cassak The medical device world is a very different a place than

Every year for just about the past decade, drug-eluting stents (DES) dominated the agenda at the Paris Course on Revascularization (PCR) – and just about any meeting where interventional cardiologists